128 related articles for article (PubMed ID: 21490695)
1. Methionine-induced homocysteinemia impairs endothelial function in hypertensives: the role of asymmetrical dimethylarginine and antioxidant vitamins.
Tousoulis D; Bouras G; Antoniades C; Marinou K; Papageorgiou N; Miliou A; Hatzis G; Stefanadi E; Tsioufis C; Stefanadis C
Am J Hypertens; 2011 Aug; 24(8):936-42. PubMed ID: 21490695
[TBL] [Abstract][Full Text] [Related]
2. The activation of endothelin-1 pathway during methionine-induced homocysteinemia mediates endothelial dysfunction in hypertensive individuals.
Tousoulis D; Bouras G; Antoniades C; Marinou K; Miliou A; Papageorgiou N; Chatzis G; Tentolouris C; Tsioufis C; Stefanadis C
J Hypertens; 2010 May; 28(5):925-30. PubMed ID: 20160653
[TBL] [Abstract][Full Text] [Related]
3. Methionine-loading rapidly impairs endothelial function, by mechanisms independent of endothelin-1: evidence for an association of fasting total homocysteine with plasma endothelin-1 levels.
Tousoulis D; Antoniades C; Marinou K; Vasiliadou C; Bouras G; Stefanadi E; Latsios G; Siasos G; Toutouzas K; Stefanadis C
J Am Coll Nutr; 2008 Jun; 27(3):379-86. PubMed ID: 18838525
[TBL] [Abstract][Full Text] [Related]
4. Asymmetrical dimethylarginine regulates endothelial function in methionine-induced but not in chronic homocystinemia in humans: effect of oxidative stress and proinflammatory cytokines.
Antoniades C; Tousoulis D; Marinou K; Vasiliadou C; Tentolouris C; Bouras G; Pitsavos C; Stefanadis C
Am J Clin Nutr; 2006 Oct; 84(4):781-8. PubMed ID: 17023704
[TBL] [Abstract][Full Text] [Related]
5. Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans.
Böger RH; Lentz SR; Bode-Böger SM; Knapp HR; Haynes WG
Clin Sci (Lond); 2001 Feb; 100(2):161-7. PubMed ID: 11171285
[TBL] [Abstract][Full Text] [Related]
6. Relationship between S-adenosylmethionine, S-adenosylhomocysteine, asymmetric dimethylarginine, and endothelial function in healthy human subjects during experimental hyper- and hypohomocysteinemia.
Doshi S; McDowell I; Goodfellow J; Stabler S; Boger R; Allen R; Newcombe R; Lewis M; Moat S
Metabolism; 2005 Mar; 54(3):351-60. PubMed ID: 15736113
[TBL] [Abstract][Full Text] [Related]
7. Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins.
Nappo F; De Rosa N; Marfella R; De Lucia D; Ingrosso D; Perna AF; Farzati B; Giugliano D
JAMA; 1999 Jun; 281(22):2113-8. PubMed ID: 10367822
[TBL] [Abstract][Full Text] [Related]
8. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia.
Böger RH; Bode-Böger SM; Sydow K; Heistad DD; Lentz SR
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1557-64. PubMed ID: 10845872
[TBL] [Abstract][Full Text] [Related]
9. Plasma asymmetric and symmetric dimethylarginine in a rat model of endothelial dysfunction induced by acute hyperhomocysteinemia.
Magné J; Huneau JF; Borderie D; Mathé V; Bos C; Mariotti F
Amino Acids; 2015 Sep; 47(9):1975-82. PubMed ID: 25792109
[TBL] [Abstract][Full Text] [Related]
10. Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine.
Stühlinger MC; Oka RK; Graf EE; Schmölzer I; Upson BM; Kapoor O; Szuba A; Malinow MR; Wascher TC; Pachinger O; Cooke JP
Circulation; 2003 Aug; 108(8):933-8. PubMed ID: 12912818
[TBL] [Abstract][Full Text] [Related]
11. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
Sydow K; Hornig B; Arakawa N; Bode-Böger SM; Tsikas D; Münzel T; Böger RH
Vasc Med; 2004 May; 9(2):93-101. PubMed ID: 15521698
[TBL] [Abstract][Full Text] [Related]
12. The effect on endothelial function of vitamin C during methionine induced hyperhomocysteinaemia.
Hanratty CG; McGrath LT; McAuley DF; Young IS; Johnston DG
BMC Cardiovasc Disord; 2001; 1():1. PubMed ID: 11444999
[TBL] [Abstract][Full Text] [Related]
13. Asymmetric dimethylarginine determines the improvement of endothelium-dependent vasodilation by simvastatin: Effect of combination with oral L-arginine.
Böger GI; Rudolph TK; Maas R; Schwedhelm E; Dumbadze E; Bierend A; Benndorf RA; Böger RH
J Am Coll Cardiol; 2007 Jun; 49(23):2274-82. PubMed ID: 17560293
[TBL] [Abstract][Full Text] [Related]
14. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans.
Kanani PM; Sinkey CA; Browning RL; Allaman M; Knapp HR; Haynes WG
Circulation; 1999 Sep; 100(11):1161-8. PubMed ID: 10484535
[TBL] [Abstract][Full Text] [Related]
15. Effect of supplementation with B vitamins and antioxidants on levels of asymmetric dimethylarginine (ADMA) and C-reactive protein (CRP): a double-blind, randomised, factorial design, placebo-controlled trial.
O'Doherty MG; Gilchrist SE; Young IS; McKinley MC; Yarnell JW; Gey KF; Evans A; Skidmore PM; Woodside JV
Eur J Nutr; 2010 Dec; 49(8):483-92. PubMed ID: 20401662
[TBL] [Abstract][Full Text] [Related]
16. Effect of vitamin E on resistance vessel endothelial dysfunction induced by methionine.
Raghuveer G; Sinkey CA; Chenard C; Stumbo P; Haynes WG
Am J Cardiol; 2001 Aug; 88(3):285-90. PubMed ID: 11472709
[TBL] [Abstract][Full Text] [Related]
17. Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension.
Perticone F; Sciacqua A; Maio R; Perticone M; Maas R; Boger RH; Tripepi G; Sesti G; Zoccali C
J Am Coll Cardiol; 2005 Aug; 46(3):518-23. PubMed ID: 16053968
[TBL] [Abstract][Full Text] [Related]
18. Vitamins reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities.
Ulker S; McKeown PP; Bayraktutan U
Hypertension; 2003 Mar; 41(3):534-9. PubMed ID: 12623955
[TBL] [Abstract][Full Text] [Related]
19. Role of asymmetrical dimethylarginine in renal microvascular endothelial dysfunction in chronic renal failure with hypertension.
Okubo K; Hayashi K; Wakino S; Matsuda H; Kubota E; Honda M; Tokuyama H; Yamamoto T; Kajiya F; Saruta T
Hypertens Res; 2005 Feb; 28(2):181-9. PubMed ID: 16025746
[TBL] [Abstract][Full Text] [Related]
20. Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD.
Nanayakkara PW; Kiefte-de Jong JC; ter Wee PM; Stehouwer CD; van Ittersum FJ; Olthof MR; Teerlink T; Twisk JW; van Guldener C; Smulders YM
Am J Kidney Dis; 2009 Jan; 53(1):41-50. PubMed ID: 18786751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
